Literature DB >> 2158509

Regulation of macrophage activation by IL-3. I. IL-3 functions as a macrophage-activating factor with unique properties, inducing Ia and lymphocyte function-associated antigen-1 but not cytotoxicity.

G Frendl1, D I Beller.   

Abstract

Here we report that IL-3 (also referred to as multi-CSF because of its colony-stimulating activity on a variety of hemopoietic cell lineages) can function as a macrophage-activating factor (MAF). IL-3 was able to regulate the expression of class II MHC Ag and the cellular interaction molecule lymphocyte function-associated Ag-1 on the surface of murine peritoneal exudate cells. The kinetics of IL-3-induced Ia expression appeared to be distinct from that induced by either IFN-gamma, IL-4, or granulocyte-macrophage-CSF. IL-3 was also distinguished from these factors by the finding that it did not induce macrophage tumoricidal activity. In addition to its inherent MAF activities, IL-3 also showed a marked synergy with low doses of LPS (0.05 to 0.5 ng/ml) as well as IFN-gamma in Ia induction. When lymphocyte function-associated Ag-1 expression was evaluated, the effects of these stimuli appeared to be only additive. Although LPS has been shown to inhibit IFN-gamma-induced Ia expression, in our experiments this property of LPS is manifest only when present at doses greater than or equal to 50 ng/ml. At lower concentrations, LPS potentiated both IL-3- and IFN-gamma-induced class II MHC Ag expression. Data presented here also suggest that the synergistic interactions between low doses of LPS and IL-3 are not mediated by known LPS-inducible cytokines of macrophage origin, because rIL-1, TNF-alpha, or IL-6 did not enhance the response to IL-3. Because IL-3 can also participate in the regulation of IL-1 expression, it appears that IL-3 can function as a MAF which selectively regulates the accessory cell characteristics required for Ag presentation, as opposed to the cytolytic functions of the macrophage.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2158509

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Modulation of human monocyte superoxide production by recombinant interleukin-3.

Authors:  V Jendrossek; S Buth; C Stetter; M Gahr
Journal:  Agents Actions       Date:  1992-09

2.  HOTAIR but not ANRIL long non-coding RNA contributes to the pathogenesis of multiple sclerosis.

Authors:  Majid Pahlevan Kakhki; Abbas Nikravesh; Zeinab Shirvani Farsani; Mohammad Ali Sahraian; Mehrdad Behmanesh
Journal:  Immunology       Date:  2017-11-16       Impact factor: 7.397

3.  Induction of the expulsion of Strongyloides ratti and retention of Nippostrongylus brasiliensis in athymic nude mice by repetitive administration of recombinant interleukin-3.

Authors:  T Abe; H Sugaya; K Yoshimura; Y Nawa
Journal:  Immunology       Date:  1992-05       Impact factor: 7.397

4.  In situ expression of cytokines in human heart allografts.

Authors:  E Van Hoffen; D Van Wichen; I Stuij; N De Jonge; C Klöpping; J Lahpor; J Van Den Tweel; F Gmelig-Meyling; R De Weger
Journal:  Am J Pathol       Date:  1996-12       Impact factor: 4.307

5.  Dysregulated hematopoiesis and a progressive neurological disorder induced by expression of an activated form of the human common beta chain in transgenic mice.

Authors:  R J D'Andrea; D Harrison-Findik; C M Butcher; J Finnie; P Blumbergs; P Bartley; M McCormack; K Jones; R Rowland; T J Gonda; M A Vadas
Journal:  J Clin Invest       Date:  1998-12-01       Impact factor: 14.808

6.  Regulation of Fc receptor and major histocompatibility complex antigen expression on isolated rat microglia by tumour necrosis factor, interleukin-1 and lipopolysaccharide: effects on interferon-gamma induced activation.

Authors:  A J Loughlin; M N Woodroofe; M L Cuzner
Journal:  Immunology       Date:  1992-01       Impact factor: 7.397

7.  IL-2, IL-3, and IFN-gamma differently affect in vivo frequencies of circulating precursors of cytotoxic T lymphocytes (CTL-P).

Authors:  F Hladik; K Kolbe; E U Irschick; M J Aman; G Gerken; L Färber; E Liehl; C Peschel; W E Aulitzky; C Huber
Journal:  Ann Hematol       Date:  1993-08       Impact factor: 3.673

8.  Killing of Mycobacterium tuberculosis within human monocytes: activation by cytokines and calcitriol.

Authors:  M Denis
Journal:  Clin Exp Immunol       Date:  1991-05       Impact factor: 4.330

9.  Macrophage/microglial-mediated primary demyelination and motor disease induced by the central nervous system production of interleukin-3 in transgenic mice.

Authors:  C S Chiang; H C Powell; L H Gold; A Samimi; I L Campbell
Journal:  J Clin Invest       Date:  1996-03-15       Impact factor: 14.808

10.  The roles of macrophages and nitric oxide in interleukin-3-enhanced HSV-Sr39tk-mediated prodrug therapy.

Authors:  Ching-Fang Yu; Ji-Hong Hong; Chi-Shiun Chiang
Journal:  PLoS One       Date:  2013-02-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.